• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR INC. SUPERA; STENT, SUPERFICIAL FEMORAL ARTERY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR INC. SUPERA; STENT, SUPERFICIAL FEMORAL ARTERY Back to Search Results
Model Number S-50-120-120-P6
Medical Device Problem Codes Material Separation (1562); Stretched (1601); Patient-Device Incompatibility (2682)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 10/14/2025
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Manufacturer's investigation is still pending at this time.Results and conclusions will be provided in the final report.
 
Event or Problem Description
It was reported that the procedure was to treat a lesion in the left superficial femoral (sfa) artery.The 5.0x120mm supera self expanding stent system (ses) was advanced to the target lesion and the stent deployed; however a waist was noted in the proximal segment of the stent.During retraction of the ses the nose cone became caught in a very tight lesion in the anatomy and stretched and then separated, remaining on the 0.18 guide wire in the anatomy.The tip of a thrombectomy catheter was used to snare the nose cone and pull it back into the catheter, removing it from the anatomy.The procedure was completed without further issues.There was no adverse patient sequela and no reported clinically significant delay in the procedure or therapy.No additional information was provided.
 
Additional Manufacturer Narrative
A visual inspection, functional testing, dimensional analysis was performed on the returned device.The separation and stretch were confirmed.The patient-device incompatibility is related to case conditions and cannot be replicated in an lab environment.Production record and corrective and preventative actions (capa) reviews were performed and revealed no indication of a product quality issue.Additionally, a query of the complaint handling database for the reported lot revealed there is no indication of a lot specific issue.Based on the reported information and the observations from the returned analysis, the investigation determined that the reported issue appears to be related to circumstances of the procedure.In this case, the tip caught anatomy (tight lesion) and was pulled off during removal.There is no indication of a product quality issue with respect to the design, manufacture, or labeling of the device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SUPERA
Common Device Name
STENT, SUPERFICIAL FEMORAL ARTERY
Manufacturer (Section D)
ABBOTT VASCULAR INC.
3200 lakeside drive
santa clara CA 95054 2807
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 2024168
26531 ynez road
temecula CA 92591 4628
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key23451836
Report Number2024168-2025-11300
Device Sequence Number18394399
Product Code NIP
UDI-Device Identifier08717648211775
UDI-Public(01)08717648211775(17)260930(10)4101161
Combination Product (Y/N)N
Initial Reporter StateMA
Initial Reporter CountryUS
PMA/510(K) Number
P120020
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2025
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 12/02/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date09/30/2026
Device Model NumberS-50-120-120-P6
Device Catalogue NumberS-50-120-120-P6
Device Lot Number4101161
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 10/14/2025
Supplement Date Received by Manufacturer11/18/2025
Initial Report FDA Received Date11/03/2025
Supplement Report FDA Received Date12/02/2025
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured10/11/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age71 YR
Patient SexFemale
Patient Weight66 KG
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-